Amyloidosis definition overview

Amyloidosis describes a collection of uncommon diseases that occur when amyloid proteins build up in different tissues and organs. These proteins are abnormal forms of normally harmless proteins, but when they misfold, they collect in the body and interfere with the way organs work. Over time, these deposits may damage important organs such as the heart, kidneys, liver, nervous system, and digestive tract. The impact of amyloidosis depends on where the amyloid proteins settle and how much they accumulate, often leading to a range of symptoms. Early recognition is important because the disease can progress and affect a person’s quality of life.

Types of Amyloidosis

There are several types of amyloidosis, each distinguished by the specific amyloid protein involved and its underlying cause. The most common forms include primary amyloidosis, also known as AL amyloidosis, which originates from abnormal plasma cells producing light chain proteins. Secondary amyloidosis, or AA amyloidosis, typically develops as a complication of chronic inflammatory or infectious conditions. Other less common types involve hereditary factors, such as familial amyloid polyneuropathy, caused by genetic mutations, or localized forms where amyloid deposits are confined to a specific tissue or organ.

Causes and Risk Factors

The precise cause of amyloidosis varies depending on its type. In primary amyloidosis, abnormal plasma cells produce excess light chains that misfold and form amyloid deposits. Chronic inflammatory diseases or persistent infections can lead to secondary amyloidosis, as sustained inflammation prompts the liver to produce serum amyloid A protein, which can deposit in tissues. Genetic mutations can also predispose individuals to hereditary forms of amyloidosis. Certain risk factors include age, with the condition more common in older adults, and a history of chronic inflammatory or infectious diseases.

Signs and Symptoms

The symptoms of amyloidosis depend on which organs are affected and the extent of amyloid deposits. When the heart is involved, individuals may experience symptoms like shortness of breath, fatigue, and irregular heartbeat. Kidney involvement can lead to swelling, proteinuria, and potential kidney failure. Nervous system involvement might cause numbness, tingling, or difficulties with coordination. Gastrointestinal symptoms can include weight loss, diarrhea, or malabsorption. Because symptoms are often nonspecific, diagnosis can be challenging and requires a comprehensive evaluation.

Diagnosis and Detection

Diagnosing amyloidosis involves a combination of clinical assessments, laboratory tests, imaging studies, and tissue biopsies. A tissue biopsy from affected organs or accessible tissues, stained with special dyes, helps confirm the presence of amyloid deposits. Advanced techniques like electron microscopy or specialized protein typing can identify the specific amyloid protein involved. Blood and urine tests may reveal abnormal proteins, and imaging studies can assess organ enlargement or damage. Early detection relies on a high index of suspicion, especially in individuals with unexplained organ dysfunction.

Conclusion